Le Lézard
Classified in: Health, Science and technology
Subject: PDT

The Future of Clinical Care is Here: United We Care Unveils Stella, the Groundbreaking AI Clinical Co-pilot


NEW YORK, July 2, 2024 /PRNewswire/ -- United We Care, a leader in AI-powered mental healthcare solutions, unveils Stella Clinical Copilot. This innovative AI assistant empowers clinicians to reclaim up to 40% of their weekly workload, allowing them to focus on what truly matters - their patients.

Overwhelmed by administrative tasks, clinicians often have limited time for quality patient interactions. Stella tackles this challenge by automating processes and streamlining workflows. Clinical Copilot is built on four pillars of success:

Here's how Stella Clinical Co-pilot delivers on these promises: 

Beyond Efficiency, Stella Bolsters Clinical Decision-Making: 

Stella uses advanced graph neural networks to analyze medical data, uncovering complex relationships between symptoms, diagnoses, and treatments. This provides clinicians with real-time, personalized insights for better decision-making and improved patient outcomes.

"Stella Clinical Co-Pilot is set to revolutionize clinical note-taking and streamline administrative tasks for healthcare professionals. It offers advanced patient data management, automated note generation, and seamless integration capabilities, significantly reducing the administrative burden on clinicians and enhancing overall healthcare efficiency," says Ritu Mehrotra, Founder and CEO at United We Care.  

United We Care remains dedicated to harnessing the power of AI to improve mental health and well-being globally. Learn more about Stella Clinical Co-pilot and how it can transform your practice at www.unitedwecare.com

Media Contact: 

Ravi Kikan
Global CMO
[email protected]  
+1 (646) 522-1483

Photo: https://mma.prnewswire.com/media/2429778/Stella_Clinical_Co_Pilot.jpg
Logo: https://mma.prnewswire.com/media/2452869/United_We_Care_Logo.jpg

SOURCE United We Care Inc


These press releases may also interest you

at 15:04
In the news release, Menarini's cell based non-invasive prenatal technology demonstrates high resolution detection of fetal genomic abnormalities from a simple maternal blood draw, issued 02-Jul-2024 by Menarini Silicon Biosystems over PR Newswire,...

at 14:53
The Alzheimer's Association celebrates today's U.S. Food and Drug Administration (FDA) action to approve Kisunlatm (donanemab, Eli Lilly) for the treatment of people living with early symptomatic Alzheimer's disease, which includes mild cognitive...

at 14:45
Alleva, a premier provider of electronic medical record (EMR) software solutions tailored for the behavioral health and addiction recovery sectors, is proud to announce its inclusion in the Software Advice FrontRunners for HIPAA Compliance Software...

at 14:37
Statement attributable to:Octavia Peck Palmer, PhDPresident, Association for Diagnostics & Laboratory Medicine (formerly AACC) "On June 28, in Loper Bright Enterprises v. Raimondo, the Supreme Court overturned the so-called Chevron doctrine and...

at 14:24
NanoCellect Biomedical, a leader in microfluidic cell sorting technology, proudly announces the launch of VERLOtm Image-Guided Cell Sorter, a groundbreaking cell sorter poised to redefine the landscape of single-cell visualization and gentle flow...

at 14:00
Revive Therapeutics Ltd. ("Revive" or the "Company") , a specialty life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders, announced today...



News published on and distributed by: